OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide

OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide

Pediatric patients with bone fractures and skeletal deformities represent ideal use case for revolutionary orthopedic fixation technology by obviating need for secondary procedures to remove hardware

Solving for skeletal immaturity

In striking an exclusive distribution agreement with OrthoPediatrics Corp. announced today, OSSIO Inc. expands access to its revolutionary orthopedic fixation technology — bio-integrative, metal-free OSSIOfiber® implants — to the approximately 400 U.S. children’s hospitals and care facilities whose orthopedic surgeons treat most pediatric patients admitted with bone fractures and skeletal deformities.

"It’s not often that kids need implants for broken bones, since most pediatric fractures can be treated without surgery,” said Dr. Jue Cao, M.D., a Denver-based orthopedic surgeon with specialty fellowship training in pediatric orthopedics, including hand surgery, and an Assistant Professor in the Department of Orthopedics at the University of Colorado School of Medicine and Children’s Hospital Colorado. “But when a child does need surgery, I sit down with them and their parents to explain the options.”